Cheung, Andy Yiu Leung 張耀樑
Some data are hidden to fit your display. Rotate?
| Organisation | From | Until | Service years |
Total Return |
CAGR total return |
CAGR relative return |
||
|---|---|---|---|---|---|---|---|---|
| 1 | Adagene Inc. | 2021-02 | 4.97 | |||||
| 2 | * | CanSino Biologics Inc. | 2024-02-21 | 1.96 | 97.35% | 41.52% | 6.56% | |
| 3 | ERNST & YOUNG (ASIA-PACIFIC) SERVICES LIMITED | 2018-08-16 | 2020-06-30 | 1.87 | ||||
| 4 | Ernst & Young (HK) | 2020-06 | - | |||||
| 5 | ERNST & YOUNG OCEANIA LIMITED | 2018-07-01 | 2020-06-30 | 2.00 | ||||
| 6 | * | Genscript Biotech Corporation | 2024-04-12 | 1.82 | -2.27% | -1.26% | -26.49% | |
| 7 | * | Hua Medicine | 2023-01-01 | 3.10 | -23.24% | -8.20% | -19.22% | |
| 8 | * | JW (Cayman) Therapeutics Co. Ltd | 2020-10-22 | 2024-08-28 | 3.85 | -93.95% | -52.06% | -49.44% |
| Average | -5.00% | -22.14% |
* = is or was HK primary-listed
Total returns are measured from the latest of the start date, the appointment date and 3-Jan-1994 until the earliest of the end date, the resignation/removal date and the last trading date. CAGR is the annualised return and is not shown for periods under 180 days. Relative returns are to the Tracker Fund of HK (2800), starting from the latest of 12-Nov-1999, the appointment date and the chosen start date.
Webb-site Database - Powered By Linux Group